Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and PK of AZD7594 (Velsecorat) in Healthy Males
NCT02648438Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2016
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of velsecorat in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by AstraZeneca. Primary endpoint: Pulmonary Bioavailability After Inhalation. Started Jan 2016; status: completed.
02
Drugs
velsecorat
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02648438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02648438.